Jensen DM - Search Results

1

Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.

Pho MT, Jensen DM, Meltzer DO, Kim AY, Linas BP. Pho MT, et al. Among authors: jensen dm. J Viral Hepat. 2015 Aug;22(8):630-8. doi: 10.1111/jvh.12412. J Viral Hepat. 2015. PMID: 26135026 Free PMC article.

2

Co-management between hospitalist and hepatologist improves the quality of care of inpatients with chronic liver disease.

Desai AP, Satoskar R, Appannagari A, Reddy KG, Te HS, Reau N, Meltzer DO, Jensen D. Desai AP, et al. J Clin Gastroenterol. 2014 Apr;48(4):e30-6. doi: 10.1097/MCG.0b013e3182a87f70. J Clin Gastroenterol. 2014. PMID: 24100752

3

A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.

Jacobson IM, Pawlotsky JM, Afdhal NH, Dusheiko GM, Forns X, Jensen DM, Poordad F, Schulz J. Jacobson IM, et al. Among authors: jensen dm. J Viral Hepat. 2012 May;19 Suppl 2:1-26. doi: 10.1111/j.1365-2893.2012.01590.x. J Viral Hepat. 2012. PMID: 22404758 Review.

4

First phase hepatitis c viral kinetics in previous nonresponders patients.

Cotler SJ, Layden JE, Neumann AU, Jensen DM. Cotler SJ, et al. Among authors: jensen dm. J Viral Hepat. 2003 Jan;10(1):43-9. doi: 10.1046/j.1365-2893.2003.00401.x. J Viral Hepat. 2003. PMID: 12558911

5

Characterization of nonrapid virologic response patients infected with HCV genotype 1 who may relapse after standard therapy with peginterferon plus ribavirin.

Reau N, Hamzeh FM, Lentz E, Zhou X, Jensen D. Reau N, et al. J Viral Hepat. 2012 Feb;19(2):94-102. doi: 10.1111/j.1365-2893.2010.01422.x. Epub 2011 Jan 12. J Viral Hepat. 2012. PMID: 22239499 Free PMC article.

6

Interferon-combination strategies for the treatment of chronic hepatitis C.

Aronsohn A, Jensen D. Aronsohn A, et al. Semin Liver Dis. 2014 Feb;34(1):30-6. doi: 10.1055/s-0034-1371008. Epub 2014 Apr 29. Semin Liver Dis. 2014. PMID: 24782256 Review.

7

Future therapies for chronic hepatitis C.

Dabbouseh NM, Jensen DM. Dabbouseh NM, et al. Among authors: jensen dm. Nat Rev Gastroenterol Hepatol. 2013 May;10(5):268-76. doi: 10.1038/nrgastro.2013.17. Epub 2013 Feb 19. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23419289 Review.

8

Retreatment of chronic hepatitis C in previous non-responders and relapsers.

Satoskar R, Jensen DM. Satoskar R, et al. Among authors: jensen dm. Expert Opin Pharmacother. 2007 Oct;8(15):2491-503. doi: 10.1517/14656566.8.15.2491. Expert Opin Pharmacother. 2007. PMID: 17931085 Review.

9

Future directions in therapy for chronic hepatitis C.

Jensen DM, Ascione A. Jensen DM, et al. Antivir Ther. 2008;13 Suppl 1:31-6. Antivir Ther. 2008. PMID: 18432161 Review.

10

Factors associated with rapid and early virologic response to peginterferon alfa-2a/ribavirin treatment in HCV genotype 1 patients representative of the general chronic hepatitis C population.

Rodriguez-Torres M, Sulkowski MS, Chung RT, Hamzeh FM, Jensen DM. Rodriguez-Torres M, et al. Among authors: jensen dm. J Viral Hepat. 2010 Feb 1;17(2):139-47. doi: 10.1111/j.1365-2893.2009.01157.x. Epub 2009 Aug 5. J Viral Hepat. 2010. PMID: 19674282 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

446 results

Search Page

Filters